Recent Articles from Business Wire

CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today introduced AlloSeq Nano, a nanopore‑based HLA (human leukocyte antigen) and ABO blood type genotyping solution, at the European Federation for Immunogenetics (EFI) Conference 2026.

Metropolitan Commercial Bank (“MCB” or the “Bank”) today announced that Jessica Raffo has joined the Bank as Vice President and Director of Association Banking for the Florida region, further strengthening the Bank’s expansion across the state.

Surf Air Mobility Inc. (NYSE: SRFM) ("Surf Air Mobility" or the "Company"), a leading air mobility platform, today announced revised 2026 guidance for Adjusted EBITDA loss of $30 to $25 million, an approximate 40% improvement from the prior Adjusted EBITDA loss of $50 to $40 million. This improvement reflects the impact of the Company's proprietary SurfOSTM software across its operations and the reduced cost and speed of its deployment. The Company reaffirmed its 2026 revenue guidance of $128 to $138 million, a 20% to 30% year-over-year increase.

BNB Plus Corp. (Nasdaq: BNBX) ("BNB Plus" or the "Company"), a Nasdaq-listed digital asset treasury company focused on Binance's BNB token, today announced that its Board of Directors has authorized a formal review of strategic alternatives to maximize shareholder value and also provided an update on its Nasdaq listing status.

RareCyte®, a leader in precision biology products and technologies, today announced a significant expansion of its spatial proteomics portfolio with the commercial launch of the Orion™ HT and Orion™ LE systems, alongside the appointment of Neil Kennedy as President. These advancements position the company to accelerate adoption of spatial proteomics in clinical and translational research.

Accelsius, the leader in two-phase, direct-to-chip liquid cooling technology for AI and high-performance computing, today announced the general availability of the NeuCool® IR150, the industry’s first fully integrated rack-level cooling solution that combines a two-phase Coolant Distribution Unit (CDU), 42U of IT rack space, and built-in liquid and vapor manifolds in a single 800mm-wide enclosure, offering up to 150kW of capacity.

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation™ (nsPFA™) energy, today announced that its nPulse™ Cardiac Catheter will be prominently featured during the Heart Rhythm Society (HRS) 2026 Annual Meeting, taking place April 23-26 in Chicago, Illinois.

Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced updates from its EphA2 pipeline at the American Association for Cancer Research (AACR) Annual Meeting 2026.

NielsenIQ (NYSE: NIQ), a global leader in consumer intelligence, today announced a strategic collaboration between NIQ Brandbank and Prodx to deliver a unified, end‑to‑end data foundation that transforms how U.S. retailers power digital shopping experiences.

Ingles Markets, Incorporated (NASDAQ: IMKTA) today issued the following open letter to shareholders:

AECOM (NYSE: ACM), the trusted global infrastructure leader, today announced that it intends to issue its second quarter fiscal 2026 earnings results after the U.S. market closes on May 11, 2026. The Company will also host a conference call and webcast with analysts and investors on May 12, 2026, at 8 a.m. Eastern Time / 7 a.m. Central Time, during which management will present the Company's financial results and outlook, strategic accomplishments, and market and business trends.

Bank of Hawai‘i Corporation (NYSE: BOH) (the “Company”) today reported diluted earnings per common share of $1.30 for the first quarter of 2026, compared with $1.39 during the linked quarter. Net income for the quarter was $57.4 million, down 5.7% from the linked quarter. The return on average common equity for the first quarter of 2026 was 13.90% compared with 15.03% during the linked quarter.

Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Tuesday, May 5, 2026 at 9:00 a.m. ET to discuss results from operations for the quarter ended March 31, 2026. A detailed press release will be issued the morning of May 5, 2026 before the securities markets open.

Sable Offshore Corp. (“Sable,” or the “Company”) (NYSE: SOC) today provided a corporate update on current operational, legal and financial matters.

Wallbox N.V. (NYSE: WBX) (“Wallbox” or the “Company”, and together with its consolidated subsidiaries, the “Group”), a global provider of electric vehicle charging and energy management solutions, has completed the creditor accession process for its previously announced financial restructuring plan, with HSBC and Citibank among the creditors joining the plan.

Summer Road LLC (“Summer Road” or “we”), the beneficial owner of approximately 3% of the outstanding shares of Class A common stock of Ingles Markets, Incorporated (NASDAQ: IMKTA) (“Ingles” or the “Company”), today announced that all three independent proxy advisory firms, Institutional Shareholder Services Inc. (“ISS”), Glass, Lewis & Co., LLC (“Glass Lewis”) and Egan-Jones Ratings Company (“Egan-Jones”), have recommended shareholders vote for the election of Summer Road nominee Rory A. Held to Ingles’ Board of Directors (the “Board”) at the 2026 Annual Meeting of Shareholders.

Innovative Industrial Properties, Inc. (IIP) (NYSE: IIPR) announced today it will report its first quarter 2026 results after the close of trading on the New York Stock Exchange on Monday, May 4, 2026.

Grovecourt Capital, a private equity firm focused on partnering with founder-owned businesses, today announced its investment in Guide Architecture, a Dallas-based healthcare-focused architecture and planning firm serving leading health systems across the United States.

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that CEO Kabir Nath will participate in a panel entitled “Clinical Risk, Regulatory Reality and the Path to Scale” at the Needham Virtual Psychedelics Forum on April 27, 2026, at 11am-12pm ET.

lululemon (NASDAQ:LULU) today announced it has launched its e-commerce channel in Mexico as it scales its integrated retail and digital presence and omnichannel capabilities in the market. The new e-commerce site enhances its guest experience and is complemented by lululemon’s plans to increase its store footprint in Mexico in fiscal year 2026, underscoring the company’s continued growth opportunity in the region.

Walker & Dunlop, Inc. announced today that it arranged a $105 million loan to refinance Maeve, a newly delivered 297-unit luxury high-rise community located in an opportunity zone in the heart of Raleigh’s Warehouse District. The Economic Opportunity Zone census tract is a program established by Congress through the Tax Cuts and Jobs Act of 2017 to encourage long-term investment in designated low-income communities through incentives such as deferred or reduced capital gains taxes.

Trane Technologies plc (NYSE: TT), a global climate innovator, today announced that company leadership will participate in a fireside chat at the Oppenheimer Industrial Growth Conference. They will speak at 11:15 a.m. ET on Tuesday, May 5, 2026.

Cleveland-Cliffs Inc. (NYSE: CLF) today reported first-quarter results for the period ended March 31, 2026.

QXO, Inc. (NYSE: QXO), following the announcement yesterday of its agreement to acquire TopBuild Corp. (NYSE: BLD) (“TopBuild”), has posted a recorded investor presentation to provide additional detail regarding the transaction.

Ennis, Inc. (the “Company”), (NYSE: EBF), today reported financial results for the quarter and fiscal year ended February 28, 2026. Highlights include:

BRC Inc. (NYSE: BRCC, the "Company" or "Black Rifle"), a Veteran-founded, mission-driven, premium beverage company, today announced it will release the first quarter 2026 financial results on Monday, May 4, 2026, after market close. The Company will host a conference call to discuss the results the following morning, Tuesday, May 5, 2026, at 8:30 a.m. ET.

Dole plc (NYSE: DOLE) (the “Company”) will announce its financial results for the first quarter of 2026 on Monday, May 11, 2026 prior to the market opening. The Company’s management will host a webcast on the same day at 08:00 a.m. Eastern Time.

TechCreate Group Ltd. (NYSE American: TCGL) (“TechCreate” or the “Company”), a technology consultancy and advanced software solutions provider specializing in payment solutions, cybersecurity, and digital services, announced its intention to collaborate with pQCee Pte Ltd, a quantum cybersecurity solutions provider, to explore the incorporation of NIST (National Institute of Standards and Technology) approved Post-quantum cryptography (PQC) algorithms in the Company’s QR Hybrid POS terminals.

Substance Wines, the Washington-based brand from O’Neill Vintners & Distillers, a B Corp Certified, family owned and operated company, is proud to announce the launch of its 2025 'Ri' Riesling (SRP $14). Crafted by Winemaker Brennon Leighton, this new single-vineyard offering reinforces the brand’s commitment to high-quality low-intervention winemaking while highlighting the distinct terroir of Washington State.

MBRYONICS has been expanding its partner and customer ecosystem and has recently been selected by the European Space Agency (ESA) for in-orbit demonstration activities in a team led by Kepler Communications. The €18.6M award is under Element 3 of the High-throughput Optical Network (HydRON) program, a project under ESA’s Optical and Quantum Communications – ScyLight program, within the agency’s Advanced Research in Telecommunications Systems (ARTES).

ILOS Projects (“ILOS”), a Pan-European Independent Power Producer (IPP) supported by BNP Paribas Asset Management Alts (BNPP AM Alts), today announced the successful upsizing of its structured credit facility with EIG, a leading institutional investor in the global energy and infrastructure sectors, and La Caisse, a global investment group, for a total of €450 million.

Strategic Capital, Inc.:

QAD | Redzone, the company redefining manufacturing and supply chains through intelligent, adaptive solutions, announced that Redzone, its frontline empowerment layer, is participating in Hannover Messe 2026, April 20-24 in Hannover, Germany.

H2SITE, a technology company specialised in advanced hydrogen production and separation solutions, has signed a strategic agreement with Petronor, a leading refinery and key industrial player in the energy sector with a clear commitment to achieving net-zero emissions, to deploy its high-efficiency hydrogen separation technology at Petronor’s refinery.

Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future,” “FF” or the “Company”), a California-based global Embodied AI (EAI) ecosystem company, today announced that the Company has signed a $45 million financing agreement (the “Agreement”) with a U.S. institutional investor (the “Investor”), with the full amount received on the same day. The proceeds will significantly support the execution of the Company’s EAI (Embodied AI) ecosystem strategy.

Australia’s non-life insurance industry has been resilient against an increasingly complex and interconnected risk landscape, with total insurance revenue for the non-life market reaching approximately AUD 77.7 billion (USD 54.1 billion) for the fiscal year ended 30 June 2025.

Synthetic Design Lab, a next-generation antibody-drug conjugate (ADC) and protein engineering company, presented preclinical data in an oral presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026 demonstrating that its proprietary SYNTHBODY™ therapeutic platform delivers log-order improvements in internalization, potency, and efficacy compared to current ADCs. The presentation marks the company's first public disclosure of platform and lead candidate data and introduces a new paradigm for ADC and biologic therapy design.

EpiBiologics, a leader in tissue-selective extracellular protein degradation, today announced that the first patient has been dosed with EPI-326 in its global Phase 1 clinical study. EPI-326 is the company’s tissue-selective bispecific antibody that degrades all oncogenic mutant and wild type forms of EGFR for EGFR-driven cancers. The first-in-human study is evaluating EPI-326 in patients with advanced non-small cell lung cancer (NSCLC) and head and neck squamous cell carcinoma (HNSCC) with the potential to expand into colorectal cancer (CRC).

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of TopBuild Corp. (NYSE: BLD) to QXO, Inc. Under the terms of the proposed transaction, TopBuild shareholders will have the right to elect to receive $505.00 in cash or 20.2 shares of QXO common stock for each TopBuild share held.

Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of PayPal Holdings, Inc. (NASDAQ: PYPL) common stock between February 8, 2024 and February 2, 2026, inclusive (the “Class Period”). PayPal enables digital payments.

Exit Planning Institute® (EPI), the leading authority on exit planning for advisors, business consultants and business owners, announced today the winners of the annual Excellence in Exit Planning Awards. Renee Russo has been selected as the 2026 Peter Christman Exit Planner of the Year for advancing the profession through her dedication to owner education and her involvement in the exit planning community.

QXO, Inc. (NYSE: QXO) today announced that it has entered into a definitive agreement to acquire TopBuild Corp. (NYSE: BLD) (“TopBuild”) for approximately $17 billion, significantly expanding QXO’s scale and capabilities across the building products value chain. The transaction is expected to be immediately and substantially accretive to the company’s earnings.

Impact Capital Group, Inc. (“Impact”), a lower middle market investment banking and valuation firm, today announced the release of a new analysis examining how owned and leased real estate can materially influence private company sale transactions.

Researchers from Inocras, a bioinformatics-led company harnessing the power of whole-genome data and proprietary analytics to advance precision health, and the Broad Institute of MIT and Harvard will jointly present new insights from a collaborative initiative to analyze large-scale whole genome data during the AACR Annual Meeting 2026 in San Diego. The collaboration delivers one of the largest cancer whole-genome analyses from over 8,000 cancer whole-genomes, generated by the NCI’s The Cancer Genome Atlas (TCGA), across more than 30 cancer types.

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, welcomes the White House Executive Order on accelerating medical treatments for serious mental illness.

This week, the nationally recognized law firm Baron & Budd announced the finalization of a $774 million nationwide settlement agreement with retail pharmacy giant Albertsons Companies, Inc. Albertsons has agreed to the payout which will be distributed to states, counties, municipalities, and Native American tribes to resolve allegations concerning the company’s role in the opioid epidemic.

Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of securities of Enphase Energy, Inc. (NASDAQ: ENPH) between April 22, 2025 and October 28, 2025, inclusive (the “Class Period”). Enphase is a energy technology company.

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced new data from a preclinical study of ZL-1503, demonstrating that the company’s internally developed IL-13/IL-31Rα bispecific antibody may lead to sustained suppression of intense pruritus (itch) and inflammation caused by atopic diseases. The findings, featured in a poster presentation at the IMMUNOLOGY2026 conference in Boston, MA, reinforce the potential of ZL-1503 to be a first-in-class treatment option for moderate-to-severe atopic dermatitis and other IL-13 and IL-31-driven diseases.

The law firm of Kirby McInerney LLP continues its investigation on behalf of The Simply Good Foods Company (“Simply Good Foods” or the “Company”) (NASDAQ:SMPL) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices.

The law firm of Kirby McInerney LLP continues its investigation on behalf of OneMain Holdings, Inc. (“OneMain” or the “Company”) (NYSE:OMF) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices.

This week, airline catering workers employed by Flying Food Group at Los Angeles International Airport publicly shared their experiences before a Truth Commission composed of community leaders at Holman United Methodist Church.

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into The Trade Desk, Inc. (“Trade Desk” or the “Company”) (NasdaqGM: TTD).

The board of directors of Phillips 66 (NYSE: PSX) has declared a quarterly dividend of $1.27 per share on Phillips 66 common stock. The dividend is payable on June 1, 2026, to shareholders of record as of the close of business on May 18, 2026.

Suite Studios, a cloud-native platform that connects creative teams to their media in real time, now has their file-streaming technology embedded in Frame.io Drive, a new desktop application from leading creative management platform, Frame.io, an Adobe company.

Saba Capital Management, L.P. (together with certain of its affiliates, “Saba”) today announced that it has entered into a standstill agreement with Virtus Investment Advisers, LLC and Virtus Dividend, Interest & Premium Strategy Fund (NYSE: NFJ) (the “Fund”).

The postponement of Blue Cross Blue Shield of Michigan’s (BCBSM) proposed reimbursement policy affecting evaluation and management (E/M) services billed with modifier 25 marks a critical step in safeguarding accurate physician reimbursement, reducing administrative burden and protecting patient access to timely, high-quality care. The decision, announced April 15, follows significant feedback from osteopathic physicians and organized medicine regarding the policy’s operational challenges, implications for payment accuracy and potential impact on health care delivery.

Saltchuk Marine, LLC and Harbor Docking & Towing (HDT) today announced the formation of Green Tug Towing (GTT), a new joint venture company established to provide towage, escort, and terminal support services in the United States. GTT has been awarded a 20-year services contract by Woodside Energy to design, build, and operate four advanced hybrid escort tugboats to support LNG carrier operations at the company’s new Calcasieu Parish terminal.

Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, today announced a price increase for a range of engineered materials products in response to various factors, including recent market developments and global supply chain disruptions.

Davidson Bogel Real Estate (DB2RE) successfully facilitated the acquisition of an 8.5-acre, four-owner industrial land assemblage located at 421, 451, 475, and 493 Bennett Lane in Lewisville.

Cerebras Systems Inc. (“Cerebras”) today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of its Class A common stock. The number of shares of Class A common stock to be offered and the price range for the proposed offering have not yet been determined. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or other terms of the offering.

Scholar Rock (NASDAQ: SRRK; the “Company”) today announced that the company granted inducement equity awards covering an aggregate of 89,304 shares of its common stock to nine newly hired employees, consisting of inducement stock options to purchase an aggregate of 38,331 shares of common stock and inducement restricted stock units, covering an aggregate of 50,973 shares of its common stock.

GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for prescription savings in the U.S., today announced it will release its first quarter 2026 financial results after U.S. markets close on Wednesday, May 6, 2026. GoodRx management will also hold a conference call and webcast the following morning, Thursday, May 7, 2026 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company’s business outlook.

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to new employees.

Avangrid, Inc., a leading energy company and member of the Iberdrola Group, announced it was recognized as a 22nd Annual Team Massachusetts Economic Impact Award winner by MassEcon, the state’s private sector partner in promoting business growth in Massachusetts. The award recognizes Avangrid’s outstanding contributions to the Massachusetts economy. Avangrid Deputy CEO Kimberly Harriman accepted the awards on behalf of Avangrid at the Economic Impact Awards ceremony at Gillette Stadium on Thursday, April 16, 2026.

A new research report commissioned by the District Department of Transportation reinforces what traffic expert Amy Witherite and other safety advocates have been warning: autonomous vehicles are not yet ready for unrestricted deployment in complex urban environments in complex urban environments, and a cautious, accountability-driven approach is essential.

AM Best has been named a 2026 Top Workplace by USA TODAY. The award is based on employee feedback collected via a confidential survey measuring workplace experience and engagement. USA TODAY Top Workplaces recognizes midsize and large organizations in the US that are exceeding national benchmarks for employee satisfaction.

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced clinical data indicating zocilurtatug pelitecan (zoci, formerly ZL-1310), a DLL3-targeting antibody-drug conjugate (ADC), provides rapid and robust intracranial responses in patients with previously treated extensive stage small cell lung cancer (ES-SCLC) and brain metastases as measured by independent assessment using modified Response Assessment in Neuro-Oncology for Brain Metastases (mRANO-BM) criteria, as well as promising data in patients with other neuroendocrine carcinomas (NECs). These findings, as well as preclinical data evaluating ZL-6201 (LRRC15 ADC) and ZL-1222 (PD-1/IL-12), will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2026 in San Diego.

intoDNA, a global precision medicine company that provides biopharma and clinicians with decision-grade insights into DNA damage and repair biology to reduce risk, accelerate timelines, and enable truly precise patient care, will present two posters at the 2026 American Association for Cancer Research (AACR) Annual Meeting, being held April 17-22, 2026 in San Diego, California.

SingleCell Biotechnology, a biotechnology company developing technologies to measure tumor cell behavior at single-cell resolution, today announced the presentation of new data at the American Association for Cancer Research (AACR) Annual Meeting 2026 demonstrating an integrated, high-throughput assay capable of measuring clonal tumor cell growth across thousands of individual microenvironments while preserving the full distribution of proliferative behaviors.

OncoNano Medicine, Inc. (“OncoNano”), a clinical-stage biotechnology company developing precision therapies using its proprietary nanotechnology platform, today announced it will present new preclinical data at the AACR Annual Meeting 2026. The presentations highlight the breadth of its ON-BOARD™ platform and its ability to enable effective, tumor-targeted delivery of therapeutic payloads through clinically validated ultra pH-sensitive micelle technology designed to activate within the tumor microenvironment.

Akamis Bio, a clinical-stage oncology company working to advance the standard of care in colorectal cancer, today announced early data from the on-going Phase 1b FORTRESS study of NG-350A, an oncolytic immunotherapy for the treatment of mismatch repair-proficient (pMMR) locally advanced rectal cancer (LARC). NG-350A combined with chemoradiotherapy (CRT) demonstrated a composite response rate of 50 percent across the first 10 patients who completed the 12-week active treatment period, with no serious adverse events or new safety signals identified related to NG-350A.

“Revolutionary America,” produced by Hillsdale Studios and distributed by Fathom Entertainment, the leading specialty distributor of content to theatrical partners worldwide, is Hillsdale College’s first feature-length documentary. Narrated by Tom Selleck, the film explores the Revolution through the experience of Americans between 1763-1791, bringing into focus the political principles that animated their fight for independence and self-government, as the Founding Fathers risked their “lives, fortunes, and sacred honor” in a fight for liberty that would shape a lasting republic. “Revolutionary America” will be shown in theatres from May 31-June 2, 2026.

KBRA assigns a long-term AA rating to the City of Chicago (the City) Water Revenue Bonds Project Series 2026A, Refunding Series 2026B (Forward Delivery), and Refunding Series 2026C (the Bonds). Concurrently, KBRA affirmed the AA rating for the City's outstanding Water Revenue Bonds. The Outlook is Stable.

KBRA assigns preliminary ratings to 10 classes of mortgage-backed notes from New Residential Mortgage Loan Trust 2026-NQM5 (NRMLT 2026-NQM5), a $471.1 million non-prime RMBS transaction sponsored by Rithm Capital Corp. (formerly New Residential Investment Corp.), a publicly traded (NYSE: RITM) real estate investment trust (REIT). The underlying mortgages in the subject pool were primarily originated by NewRez LLC (47.4%) and Champions Funding, LLC (21.2%). In addition, all loans will be serviced by NewRez LLC.

Turkcell (NYSE: TKC, BIST: TCELL) announced that it has filed its Annual Report on Form 20-F for the year ended December 31, 2025 with the United States Securities and Exchange Commission on April 17, 2026. The Company's Form 20-F and complete audited financial statements can be found at: https://www.turkcell.com.tr/en/aboutus/investor-relations/quarterly-results